Blood Marker Tests. Your doctor may order blood tests for cancer/tumor markers to detect cancer activity in the body. Proteins and circulating tumor cells are two types of markers that can be measured. A cancer tumor often produces a specific protein in the blood that serves as a marker for the cancer.
Zolpidem, sold as the brand name Ambien among others, is a sedative primarily used for the treatment of trouble sleeping. It usually works within 15 minutes, and has a short half-life of two to three hours. Zolpidem has not adequately demonstrated effectiveness in maintaining sleep, unless delivered in a controlled-release (CR) form.
A total of 979 adults hospitalized with cIAI received Zerbaxa 1.5 g (1 g/0.5 g IV) plus metronidazole (500 mg IV) or meropenem (1 g IV) for 4 to 14 days. The clinical cure rates at 24 to 32 days after initiation of therapy, were 83% in Zerbaxa and metronidazole arm and 87.3% in the meropenem arm. Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 2  End-stage renal disease (ESRD) patients on hemodialysis: A loading dose of Zerbaxa 750 mg IV with a maintenance dose of 150 mg, every 8 hours.